HRDetect, developed by Zainal et al., is a weighted model combing six distinguishing mutational signatures using an assay that was able to accurately identify a BRCA1/2-deficient tumour with 98.7% accuracy [110]. The gene discussed is BRCA1; the disease is neoplasm.